Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury.


Emerging metabolomic tools have created the opportunity to establish metabolic signatures of myocardial injury. We applied a mass spectrometry-based metabolite profiling platform to 36 patients undergoing alcohol septal ablation treatment for hypertrophic obstructive cardiomyopathy, a human model of planned myocardial infarction (PMI). Serial blood samples were obtained before and at various intervals after PMI, with patients undergoing elective diagnostic coronary angiography and patients with spontaneous myocardial infarction (SMI) serving as negative and positive controls, respectively. We identified changes in circulating levels of metabolites participating in pyrimidine metabolism, the tricarboxylic acid cycle and its upstream contributors, and the pentose phosphate pathway. Alterations in levels of multiple metabolites were detected as early as 10 minutes after PMI in an initial derivation group and were validated in a second, independent group of PMI patients. A PMI-derived metabolic signature consisting of aconitic acid, hypoxanthine, trimethylamine N-oxide, and threonine differentiated patients with SMI from those undergoing diagnostic coronary angiography with high accuracy, and coronary sinus sampling distinguished cardiac-derived from peripheral metabolic changes. Our results identify a role for metabolic profiling in the early detection of myocardial injury and suggest that similar approaches may be used for detection or prediction of other disease states.

DOI: 10.1172/JCI35111

11 Figures and Tables

Citations per Year

244 Citations

Semantic Scholar estimates that this publication has 244 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Lewis2008MetabolitePO, title={Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury.}, author={Gregory D. Lewis and Ru Wei and Emerson Liu and Elaine C. Yang and Xu Shi and Maryann E. Martinovic and Laurie A. Farrell and Aarti Asnani and Marcoli Cyrille and Arvind Ramanathan and Oded Shaham and Gabriel F. Berriz and Patricia A. Lowry and Igor F . Palacios and Murat Tasan and Frederick P. Roth and Jiangyong . Min and Christian Baumgartner and Hasmik Keshishian and Terri A. Addona and Vamsi K. Mootha and Anthony Rosenzweig and Steven A. Carr and Michael A . Fifer and Marc S. Sabatine and Robert E. Gerszten}, journal={The Journal of clinical investigation}, year={2008}, volume={118 10}, pages={3503-12} }